( January 27, 2026, 2:52 PM EST) -- SEATTLE — A Washington federal judge on Jan. 26 ruled that a false advertising and unfair competition case filed by the maker of semaglutide drugs can move forward, finding that the complaint established standing and sufficiently alleges the elements of claims against the compounded drug seller....